12/21
Headlines

Kristen Barton

Kristen Barton is a managing director and co-director of investment research. Kristen is also a senior research analyst focusing on agriculture & biotech companies. Prior to joining Tech Insider in 2010, Barton worked in equity research at RBC Capital Markets in Minneapolis, MN and Edward Jones in St. Louis, Mo. She was recognized for her stock picking in the 2012 Wall Street Journal "Best on the Street" publication.

Gilead Sciences GILD NASDAQ:GILD

Biotech Losers: MannKind Corporation (NASDAQ:MNKD), Rexahn Pharmaceuticals (NYSEMKT:RNN), ZIOPHARM Oncology (NASDAQ:ZIOP), Seattle Genetics (NASDAQ:SGEN)

Kristen Barton02 mins

MannKind Corporation (NASDAQ:MNKD) announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for AFREZZA(R) by three months to July 15, 2014 in order to provide time for a full review of information submitted by MannKind in response to the FDA’s requests.MannKind Corporation (NASDAQ:MNKD) stock performance…

Read More

Trader’s Alert: Yahoo! Inc. (NASDAQ:YHOO), Sprint Corporation (NYSE:S), Vodafone Group (NASDAQ:VOD), Amazon.com, Inc. (NASDAQ:AMZN)

Kristen Barton02 mins

Yahoo Inc. (NASDAQ:YHOO) and Google are among the most prominent Internet services to say they have already insulated most of the most popular services from Heartbleed. At Yahoo Inc (NASDAQ:YHOO), the repairs have been made on a list of services that includes its home page, search engine, email, finance and sport sections, Flickr photo-sharing service…

Read More

Consumer Goods Active Runners: General Motors (NYSE:GM), Ford Motor Company (NYSE:F), The Coca-Cola (NYSE:KO), Apple Inc. (NASDAQ:AAPL)

Kristen Barton02 mins

General Motors Company (NYSE:GM) is under fire for missing a deadline last week to answer 107 questions requested by the NHTSA in its investigation. On Wednesday, the agency announced it was fining the automaker $7,000 for every day it fails to comply. General Motors Company (NYSE:GM) stock performance was -0.95% in last session and finished…

Read More

Drug Delivery Most Volatile: Delcath Systems (NASDAQ:DCTH), Bio-Path Holdings (NASDAQ:BPTH), Flamel Technologies (NASDAQ:FLML), Adamis Pharmaceuticals (NASDAQ:ADMP)

Kristen Barton02 mins

Wall Street flees from troubled Delcath Systems Inc. (NASDAQ:DCTH) after the cancer-treatment devices maker proceeds with a 1-to-16 reverse stock split. Delcath Systems, Inc. (NASDAQ:DCTH) stock performance was -20.30% in last session and finished the day at $3.73. Traded volume was 1.19million shares in the last session and the average volume of the stock remained…

Read More

Diversified Machinery Most Volatile: THT Heat Transfer (NASDAQ:THTI), China Ming Yang Wind Power (NYSE:MY), Tecumseh Products (NASDAQ:TECUA), Broadwind Energy (NASDAQ:BWEN)

Kristen Barton03 mins

THT Heat Transfer Technology, Inc. (NASDAQ:THTI), a leading provider of heat exchangers and heat exchange solutions in China’s clean technology industry, announced its financial results for the fourth quarter and fiscal year ended December 31, 2013. Chairman and Chief Executive Officer Guohong Zhao commented, “We are pleased to report the 42% year-over-year revenue growth we…

Read More

Healthcare Stocks Touched New Lows: VIVUS (NASDAQ:VVUS), Akebia Therapeutics Inc (NASDAQ:AKBA), Versartis Inc (NASDAQ:VSAR), BioLife Solutions (NASDAQ:BLFS)

Kristen Barton02 mins

VIVUS Inc. (NASDAQ:VVUS) lower following news late Tuesday night that three directors — J. Martin Carroll, Mark B. Logan and Robert N. Wilson — will not stand for re-election to the company’s Board. This will be the sixth-straight session for the stock to close lower. VIVUS, Inc. (NASDAQ:VVUS) stock performance was 0.20% in last session…

Read More